医薬品医療機器法に基づく業務改善指示を行いました｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000073914.html医薬品医療機器法に基づく業務改善指示を行いました｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces that the Ministry of Health, Labour and Welfare issued a business improvement order to Gilead Sciences Inc. on February 13, 2015, based on the Pharmaceuticals and Medical Devices Law. The order was issued because the company failed to report adverse effects occurring post-market in foreign countries within the prescribed timeframe during clinical trials. The ministry instructed improvements in trial operations to ensure proper adverse effect reporting systems. Adverse effects from clinical trials in Japan and abroad have been properly reported, and all delayed information has been supplemented, with no new safety concerns identified.
